Digital Health Assistant & Symptom Checker | Symptoma
0%
Restart

Are you sure you want to clear all symptoms and restart the conversation?

About COVID-19 Jobs Press Terms Privacy Imprint Medical Device Language
Languages
Suggested Languages
English (English) en
Other languages 0
2.1
Extrapulmonary Tuberculosis

Extrapulmonary Tuberculosis (EPTB) refers to tuberculosis (TB) infections that occur outside of the lungs. While pulmonary TB affects the lungs, EPTB can affect various other parts of the body, including the lymph nodes, pleura, bones, joints, genitourinary tract, and central nervous system. EPTB is caused by the bacterium Mycobacterium tuberculosis, the same organism responsible for pulmonary TB. It is important to recognize and treat EPTB as it can lead to significant morbidity if left untreated.

Presentation

The symptoms of EPTB vary depending on the organ system involved. Common presentations include:

  • Lymph Node TB: Swollen, painless lymph nodes, often in the neck.
  • Pleural TB: Chest pain, difficulty breathing, and pleural effusion (fluid around the lungs).
  • Bone and Joint TB: Pain and swelling in the affected bones or joints, commonly the spine (Pott's disease).
  • Genitourinary TB: Symptoms may include pelvic pain, urinary frequency, and blood in the urine.
  • Central Nervous System TB: Headaches, fever, neck stiffness, and neurological deficits, often due to TB meningitis.

Systemic symptoms such as fever, night sweats, weight loss, and fatigue are common across all forms of TB.

Workup

Diagnosing EPTB involves a combination of clinical evaluation, imaging studies, and laboratory tests:

  • Clinical Evaluation: A thorough history and physical examination to identify symptoms and potential exposure to TB.
  • Imaging: X-rays, CT scans, or MRI may be used to identify abnormalities in affected areas.
  • Laboratory Tests:
    • Tuberculin Skin Test (TST) or Interferon-Gamma Release Assays (IGRAs) to detect TB infection.
    • Biopsy and Culture: Obtaining tissue or fluid samples from affected areas for culture and histopathological examination.
    • Polymerase Chain Reaction (PCR): Molecular tests to detect TB DNA in samples.

Treatment

The treatment of EPTB involves a combination of antibiotics over an extended period, typically 6 to 12 months. The standard regimen includes:

  • Isoniazid
  • Rifampicin
  • Ethambutol
  • Pyrazinamide

The exact duration and combination of drugs may vary based on the site of infection and drug susceptibility. In some cases, surgical intervention may be necessary to drain abscesses or relieve pressure on affected organs.

Prognosis

The prognosis for EPTB is generally good with appropriate treatment. However, the outcome can vary depending on the site of infection and the timeliness of diagnosis and treatment. Complications such as neurological deficits from TB meningitis or spinal deformities from bone TB can occur if treatment is delayed. Early diagnosis and adherence to the treatment regimen are crucial for a favorable outcome.

Etiology

EPTB is caused by Mycobacterium tuberculosis, a bacterium that primarily spreads through airborne droplets when an infected person coughs or sneezes. While the initial infection typically occurs in the lungs, the bacteria can spread through the bloodstream or lymphatic system to other parts of the body, leading to EPTB.

Epidemiology

EPTB accounts for a significant proportion of TB cases worldwide, particularly in regions with high TB prevalence. It is more common in individuals with weakened immune systems, such as those with HIV/AIDS, malnutrition, or other immunocompromising conditions. EPTB is also more prevalent in children and the elderly.

Pathophysiology

The pathophysiology of EPTB involves the dissemination of Mycobacterium tuberculosis from the primary site of infection in the lungs to other parts of the body. This can occur through the bloodstream or lymphatic system. The bacteria can remain dormant in the body and reactivate later, leading to EPTB. The immune response to the bacteria can cause inflammation and tissue damage in the affected organs.

Prevention

Preventing EPTB involves controlling the spread of TB infection. Key strategies include:

  • Vaccination: The Bacillus Calmette-Guérin (BCG) vaccine can provide some protection against TB, particularly severe forms in children.
  • Early Detection and Treatment: Prompt diagnosis and treatment of active TB cases to prevent spread.
  • Infection Control Measures: Use of masks, proper ventilation, and isolation of infectious patients in healthcare settings.

Summary

Extrapulmonary Tuberculosis is a form of TB that affects organs outside the lungs. It presents with a variety of symptoms depending on the affected site and requires a combination of clinical evaluation, imaging, and laboratory tests for diagnosis. Treatment involves a prolonged course of antibiotics, and the prognosis is generally good with timely intervention. Understanding the etiology, epidemiology, and pathophysiology of EPTB is crucial for effective prevention and management.

Patient Information

If you suspect you have symptoms of Extrapulmonary Tuberculosis, it is important to seek medical evaluation. Symptoms can vary widely depending on the part of the body affected, but common signs include swollen lymph nodes, chest pain, joint pain, and systemic symptoms like fever and weight loss. Diagnosis involves tests such as skin tests, blood tests, imaging, and sometimes biopsies. Treatment typically involves a long course of antibiotics, and early diagnosis can lead to better outcomes. Preventive measures include vaccination and early treatment of active TB cases to prevent spread.

Languages
Suggested Languages
English (English) en
Other languages 0
Sitemap: 1-200 201-500 -1k -2k -3k -4k -5k -6k -7k -8k -9k -10k -15k -20k -30k -50k 2.1
About Symptoma.co.uk COVID-19 Jobs Press
Contact Terms Privacy Imprint Medical Device